期刊文献+

PAR1 mRNA及蛋白在食管鳞状细胞癌中的表达及临床意义

Expression of PAR1 in Esophageal Squamous Cell Carcinoma and Its Clinical Significance
原文传递
导出
摘要 [目的]探讨PAR1 mRNA及蛋白在食管鳞状细胞癌及其匹配癌旁组织中的表达和临床意义。[方法]应用RT-PCR方法检测35例食管鳞状细胞癌患者食管原位癌组织及其匹配癌旁组织PAR1 mRNA的表达水平,并分析其与患者性别、年龄、肿瘤大小、临床分期及是否淋巴结转移等临床指标的关系;应用免疫组织化学法检测55对食管鳞癌组织及其匹配癌旁组织的PAR1蛋白表达情况。[结果]食管鳞癌组织PAR1 mRNA的表达水平显著高于其匹配的癌旁组织(146.220±24.790vs134.054±23.593,t=-4.17,P<0.01),而且与淋巴结是否转移有关(t=-2.199,P<0.05);食管鳞癌组织PAR1蛋白表达阳性率显著高于其匹配的癌旁组织(49%vs3.64%,χ2=23.04,P<0.001)。[结论]PAR1 mRNA及蛋白在食管鳞癌中的表达均显著上调,可能参与食管癌的发生发展、侵袭与转移。 [Purpose] To explore PAR1 mRNA and protein expressions in esophageal squamous cell carcinoma(ESCC) tissues and their matched cancer adjacent tissues.[Methods] The expressions of PAR1 mRNA and protein in ESCC tissues and their matched cancer adjacent tissues were detected by RT-PCR and IHC,respectively.Meanwhile,the different expressions of PAR1 mRNA in ESCC tissues between different clinicopathologic features were analyzed.[Results] The expression level of PAR1 mRNA in ESCC tissues was significantly higher than that in their matched cancer adjacent tissues(146.220±24.790 vs 134.054±23.593,t=-4.17,P0.01).ESCC patients with lymph node metastasis had a higher expression level of PAR1 mRNA(t=-2.199,P0.05).Also,there was a higher positive rate of PAR1 protein expression in ESCC tissues(49% vs 3.64%,χ2=23.04,P0.001).[Conclusion] Both PAR1 mRNA and protein expressions are upregu-lated in ESCC tissues,which might closely associate with carcinogenesis and progress of ESCC.
出处 《肿瘤学杂志》 CAS 2013年第5期336-341,共6页 Journal of Chinese Oncology
基金 中山大学2010年本科生业余科研Ⅰ项目(1163203)
关键词 蛋白酶活化受体1 食管肿瘤 鳞状细胞癌 RT-PCR 免疫组织化学 protease activated receptor(PAR1) esophageal neoplasms squamous cell carcinoma RT-PCR IHC
  • 相关文献

参考文献17

  • 1Bandla S,Pennathur A,Luketich JD,et al. Comparative genomics of esophageal adenocarcinoma and squamous cell carcinoma[J]. Ann Thorac Surg,2012,93(4):1101-1106.
  • 2Ossovskaya VS,Bunnett NW. Protease-activated receptors: contribution to physiology and disease[J]. Physiol Rev,2004, 84(2):579-621.
  • 3张晓飞,董琼珠,薛裕华,周海军,叶青海,任宁,贾户亮,钦伦秀.蛋白酶激活受体1在癌旁组织中的高表达与肝癌早期患者术后预后不良相关[J].中华肝脏病杂志,2011,19(4):266-270. 被引量:5
  • 4Du X,Wang S,Lu J,et al. Correlation between MMPI- PAR1 axis and clinical outcome of primary gallbladder carcinoma[J]. Jpn J Clin Oncol, 2011,41 (9): 1086-1093.
  • 5Cisowski J,O'Callaghan K,Kuliopulos A,et al. Targeting protease-activated receptor-I with cell-penetrating pep-ducins in lung cancer[J]. Am J Pathol, 2011,179(1):513-523.
  • 6Eroglu A,Karabiyik A,Akar N. The association of pro- tease activated receptor 1 gene-506 UD polymorphism with disease-free survival in breast cancer patients[J]. Ann Surg Onco1,2012,19(4):1365-1369.
  • 7Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation[J]. Cell, 2011,144(5 ):646-674.
  • 8Kawabata A,Kuroda R. Protease-activated receptor (PAR), a novel family of G protein-coupled seven trans-membrane domain receptors: activation mechanisms and physiological roles[J]. Jpn J Pharmacol,2000,82(3):l 71-174.
  • 9Schaffner F,Ruf W. Tissue factor and protease-activated receptor signaling in cancer[J]. Semin Thromb Hemost,2008, 34(2):147-153.
  • 10曹守冬,肖伟,张涛,吕键,艾秀华.凝血酶诱发人支气管上皮细胞恶性转化的信号转导[J].肿瘤学杂志,2009,15(5):416-419. 被引量:3

二级参考文献62

  • 1孟宇宏,张金强,朱彦君,宁浩勇,胡明,姚林,郑集义,王妍,陆应麟,虞积耀.肺癌中凝血酶受体-1的表达及意义[J].临床与实验病理学杂志,2004,20(3):308-312. 被引量:7
  • 2曹守冬,肖伟,朱茂祥,杨陟华,薛玉文.凝血酶诱发人支气管上皮细胞恶性转化[J].中国药理学与毒理学杂志,2006,20(1):53-59. 被引量:4
  • 3汤钊猷.肝癌临床研究之我见[J].中华肝脏病杂志,2006,14(7):481-482. 被引量:12
  • 4Pandya NM,Jain SM,Santani DD.Pathophysiological actions of protcase activated receptors (PARs)[J].Pharmazie,2007,62(3):163-169.
  • 5Lin CC,Shyr MH,Chien CS,et al.Thrombin-stimulated cell proliferation mediated through activation of Ras/Raf/MEK/MAPK pathway in canine cultured tracheal smooth muscle cells[J].Cell Signal,2002,14(3):265-275.
  • 6Deng X,Mercer PF,Scotton C J,et al.Thrombin induces fibroblast CCL2/JE production and release via coupling of PAR1 to Galphaq and cooperation between ERK1/2 and Rbo kinase signaling pathways[J].Mol Biol Cell,2008,19(6):2520-2533.
  • 7Calvisi DF,Pascale RM,Feo F.Dissection of signal transduction pathways as a tool for the development of targeted therapies of bepatocellular carcinoma[J].Rev Recent Clin Trials,2007,2(3):217-236.
  • 8Ram PT,Iyengar R.G protein coupled receptor signaling through the Src and Stat3 pathway:role in proliferation and transformation[J].Oncogene,2001,20(13):1601-1606.
  • 9Asokananthan N,Graham PT,Fink J,et al.Activation of protease-activatcd receptor (PAR)-1,PAR-2,and PAR-4 stimulates IL-6,IL-8,and prostaglandin E2 release from human respiratory epithelial cells[J].J Immunol,2002,168 (7):3577-3585.
  • 10Kawabata A,Kawao N.Physiology and pathophysiology of proteinase-activated receptors (PARs):PARs in the respiratory system:cellular signaling and physiological/pathological roles[J].J Pharmacol Sci,2005,97(1):20-24.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部